BIOGY
Price
$9.75
Change
-$0.40 (-3.94%)
Updated
Jul 15 closing price
Capitalization
1B
CANN
Price
$0.03
Change
+$0.01 (+50.00%)
Updated
Aug 7 closing price
Capitalization
8.96M
Interact to see
Advertisement

BIOGY vs CANN

Header iconBIOGY vs CANN Comparison
Open Charts BIOGY vs CANNBanner chart's image
Biogaia AB
Price$9.75
Change-$0.40 (-3.94%)
Volume$1K
Capitalization1B
TREES
Price$0.03
Change+$0.01 (+50.00%)
Volume$150.7K
Capitalization8.96M
BIOGY vs CANN Comparison Chart in %
Loading...
BIOGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIOGY vs. CANN commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOGY is a Buy and CANN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BIOGY: $9.75 vs. CANN: $0.03)
Brand notoriety: BIOGY and CANN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BIOGY: 144% vs. CANN: 152%
Market capitalization -- BIOGY: $1B vs. CANN: $8.96M
BIOGY [@Pharmaceuticals: Other] is valued at $1B. CANN’s [@Pharmaceuticals: Other] market capitalization is $8.96M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOGY’s FA Score shows that 1 FA rating(s) are green whileCANN’s FA Score has 0 green FA rating(s).

  • BIOGY’s FA Score: 1 green, 4 red.
  • CANN’s FA Score: 0 green, 5 red.
According to our system of comparison, BIOGY is a better buy in the long-term than CANN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOGY’s TA Score shows that 4 TA indicator(s) are bullish while CANN’s TA Score has 5 bullish TA indicator(s).

  • BIOGY’s TA Score: 4 bullish, 4 bearish.
  • CANN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BIOGY and CANN are a good buy in the short-term.

Price Growth

BIOGY (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while CANN (@Pharmaceuticals: Other) price change was -10.48% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.12%. For the same industry, the average monthly price growth was +73.14%, and the average quarterly price growth was +82.67%.

Industries' Descriptions

@Pharmaceuticals: Other (+3.12% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIOGY($1B) has a higher market cap than CANN($8.96M). CANN YTD gains are higher at: 49.444 vs. BIOGY (4.332). BIOGY has higher annual earnings (EBITDA): 529M vs. CANN (-6.77M). BIOGY has more cash in the bank: 1.37B vs. CANN (1.46M). BIOGY has higher revenues than CANN: BIOGY (1.21B) vs CANN (15M).
BIOGYCANNBIOGY / CANN
Capitalization1B8.96M11,173%
EBITDA529M-6.77M-7,808%
Gain YTD4.33249.4449%
P/E Ratio25.13N/A-
Revenue1.21B15M8,087%
Total Cash1.37B1.46M93,836%
Total DebtN/A22.9M-
FUNDAMENTALS RATINGS
BIOGY vs CANN: Fundamental Ratings
BIOGY
CANN
OUTLOOK RATING
1..100
3072
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
63
Fair valued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
43100
PRICE GROWTH RATING
1..100
5764
P/E GROWTH RATING
1..100
40100
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIOGY's Valuation (6) in the null industry is somewhat better than the same rating for CANN (63). This means that BIOGY’s stock grew somewhat faster than CANN’s over the last 12 months.

BIOGY's Profit vs Risk Rating (83) in the null industry is in the same range as CANN (100). This means that BIOGY’s stock grew similarly to CANN’s over the last 12 months.

BIOGY's SMR Rating (43) in the null industry is somewhat better than the same rating for CANN (100). This means that BIOGY’s stock grew somewhat faster than CANN’s over the last 12 months.

BIOGY's Price Growth Rating (57) in the null industry is in the same range as CANN (64). This means that BIOGY’s stock grew similarly to CANN’s over the last 12 months.

BIOGY's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for CANN (100). This means that BIOGY’s stock grew somewhat faster than CANN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOGYCANN
RSI
ODDS (%)
Bearish Trend 1 day ago
17%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
38%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
35%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
30%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
37%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
35%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
38%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
30%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BIOGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTAAX12.41N/A
N/A
Fidelity Advisor Asset Manager 30% A
VENAX59.54N/A
N/A
Vanguard Energy Index Admiral
TMMAX18.08N/A
N/A
SEI Tax-Managed Mgd Volatility F (SIMT)
SAOAX30.50N/A
N/A
NAA Opportunity A
SMINX12.96N/A
N/A
SEI Tax-Managed Intl Mgd Vol F (SIMT)

BIOGY and

Correlation & Price change

A.I.dvisor tells us that BIOGY and BIOVF have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOGY and BIOVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOGY
1D Price
Change %
BIOGY100%
N/A
BIOVF - BIOGY
11%
Poorly correlated
N/A
ARSUF - BIOGY
2%
Poorly correlated
N/A
BKUH - BIOGY
1%
Poorly correlated
N/A
CANN - BIOGY
-0%
Poorly correlated
+16.25%
CAIHF - BIOGY
-0%
Poorly correlated
N/A
More

CANN and

Correlation & Price change

A.I.dvisor tells us that CANN and MEDIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANN and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANN
1D Price
Change %
CANN100%
+16.25%
MEDIF - CANN
22%
Poorly correlated
+5.52%
SFOSF - CANN
21%
Poorly correlated
N/A
CGC - CANN
20%
Poorly correlated
N/A
CNTMF - CANN
14%
Poorly correlated
-5.71%
CAIHF - CANN
12%
Poorly correlated
N/A
More